GoodRx (GDRX) Competitors

GoodRx (NASDAQ:GDRX) and MARA (NASDAQ:MARA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings, analyst recommendations, media sentiment and community ranking.

Do analysts rate GDRX or MARA?

GoodRx presently has a consensus price target of $6.55, suggesting a potential upside of 43.70%. MARA has a consensus price target of $20.83, suggesting a potential upside of 25.54%. Given GoodRx's stronger consensus rating and higher possible upside, equities analysts clearly believe GoodRx is more favorable than MARA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GoodRx	0 Sell rating(s)	5 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.64
MARA	1 Sell rating(s)	4 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.40

Does the media refer more to GDRX or MARA?

In the previous week, MARA had 25 more articles in the media than GoodRx. MarketBeat recorded 37 mentions for MARA and 12 mentions for GoodRx. GoodRx's average media sentiment score of 0.69 beat MARA's score of 0.52 indicating that GoodRx is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
GoodRx	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
MARA	14 Very Positive mention(s)	4 Positive mention(s)	9 Neutral mention(s)	7 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has better earnings & valuation, GDRX or MARA?

MARA has lower revenue, but higher earnings than GoodRx. MARA is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GoodRx	$797.41M	2.04	-$8.87M	$0.08	56.94
MARA	$705.06M	8.28	$261.17M	-$1.45	-11.44

Is GDRX or MARA more profitable?

MARA has a net margin of 27.48% compared to GoodRx's net margin of -2.05%. GoodRx's return on equity of 5.35% beat MARA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
GoodRx	-2.05%	5.35%	2.51%
MARA	27.48%	-8.40%	-6.92%

Which has more risk and volatility, GDRX or MARA?

GoodRx has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, MARA has a beta of 6.61, meaning that its share price is 561% more volatile than the S&P 500.

Does the MarketBeat Community believe in GDRX or MARA?

MARA received 239 more outperform votes than GoodRx when rated by MarketBeat users. Likewise, 53.78% of users gave MARA an outperform vote while only 39.57% of users gave GoodRx an outperform vote.

Company	Underperform	Outperform
GoodRx	Outperform Votes 74 39.57%	Underperform Votes 113 60.43%
MARA	Outperform Votes 313 53.78%	Underperform Votes 269 46.22%

Do insiders and institutionals hold more shares of GDRX or MARA?

63.8% of GoodRx shares are held by institutional investors. Comparatively, 44.5% of MARA shares are held by institutional investors. 4.5% of GoodRx shares are held by company insiders. Comparatively, 0.8% of MARA shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

GoodRx beats MARA on 10 of the 18 factors compared between the two stocks.